HUTCHMED (LON:HCM) Stock Price Crosses Below 200-Day Moving Average - Time to Sell?

HUTCHMED (China) Limited (LON:HCM - Get Free Report)'s share price passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 250.52 ($3.32) and traded as low as GBX 217 ($2.88). HUTCHMED shares last traded at GBX 235 ($3.11), with a volume of 55,717 shares changing hands.

HUTCHMED Stock Up 10.8 %

The company has a market capitalization of £2.55 billion, a P/E ratio of -59.98 and a beta of 0.76. The company has a quick ratio of 2.97, a current ratio of 2.81 and a debt-to-equity ratio of 11.97. The company has a 50-day moving average of GBX 231.52 and a two-hundred day moving average of GBX 250.52.

About HUTCHMED

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S. We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China. HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange's AIM market (Nasdaq/AIM:HCM; HKEX:13).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.